Treatment with the experimental injection therapy claseprubart (DNTH103) was well tolerated and appeared to ease symptoms of generalized myasthenia gravis (gMG) in a Phase 2 clinical trial involving people with […] The post Claseprubart shows good safety, signs of effectiveness in gMG trial appeared first on Myasthenia Gravis News.
